Latest filing published 12 Nov 2015 for Alliqua BioMedical, Inc., €4,066.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Jeffrey Sklar: trading record in brief
All filings by Jeffrey Sklar on record concern Alliqua BioMedical, Inc. Over a trading history stretching from 2 June 2011 to 6 November 2015, the count stands at 3 filings.
Every open-market trade on record is a purchase: 3 purchases worth €6,344, and no sale. The amount is not disclosed for 1 filing. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2015: 1 purchase and no sales on the market.
On 12 November 2015 came the latest disclosure, an open-market purchase for €4,066 in Alliqua BioMedical, Inc. Filings reach the SEC (Form 4) feed a median of 5 days after the trade. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jeffrey Sklar
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,500 shares@ US$2.95Common StockSEC:0001144204-15-064396:0Canonical exit: 4 Feb 2016 (T+90)
- 1,000,000 sharesCommon StockSEC:0001354488-12-000796:0Canonical exit: 16 May 2012 (T+90)
- 30,000 shares@ US$0.11Common StockSEC:0001193805-11-001059:0Canonical exit: 31 Aug 2011 (T+90)
3 of 3 declarations